Literature DB >> 29288200

EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production.

Muyao Guo1,2, Madeline J Price1, Dillon G Patterson1, Benjamin G Barwick3, Robert R Haines1, Anna K Kania1, John E Bradley4, Troy D Randall4, Jeremy M Boss5, Christopher D Scharer5.   

Abstract

Epigenetic remodeling is required during B cell differentiation. However, little is known about the direct functions of epigenetic enzymes in Ab-secreting cells (ASC) in vivo. In this study, we examined ASC differentiation independent of T cell help and germinal center reactions using mice with inducible or B cell-specific deletions of Ezh2 Following stimulation with influenza virus or LPS, Ezh2-deficient ASC poorly proliferated and inappropriately maintained expression of inflammatory pathways, B cell-lineage transcription factors, and Blimp-1-repressed genes, leading to fewer and less functional ASC. In the absence of EZH2, genes that normally gained histone H3 lysine 27 trimethylation were dysregulated and exhibited increased chromatin accessibility. Furthermore, EZH2 was also required for maximal Ab secretion by ASC, in part due to reduced mitochondrial respiration, impaired glucose metabolism, and poor expression of the unfolded-protein response pathway. Together, these data demonstrate that EZH2 is essential in facilitating epigenetic changes that regulate ASC fate, function, and metabolism.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29288200      PMCID: PMC5780247          DOI: 10.4049/jimmunol.1701470

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  83 in total

1.  The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.

Authors:  Roger Revilla-I-Domingo; Ivan Bilic; Bojan Vilagos; Hiromi Tagoh; Anja Ebert; Ido M Tamir; Leonie Smeenk; Johanna Trupke; Andreas Sommer; Markus Jaritz; Meinrad Busslinger
Journal:  EMBO J       Date:  2012-06-05       Impact factor: 11.598

2.  B lymphocyte-specific, Cre-mediated mutagenesis in mice.

Authors:  R C Rickert; J Roes; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

3.  Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells.

Authors:  Wei Shi; Yang Liao; Simon N Willis; Nadine Taubenheim; Michael Inouye; David M Tarlinton; Gordon K Smyth; Philip D Hodgkin; Stephen L Nutt; Lynn M Corcoran
Journal:  Nat Immunol       Date:  2015-04-20       Impact factor: 25.606

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation.

Authors:  André Ballesteros-Tato; Beatriz León; Beth A Graf; Amy Moquin; Pamela Scott Adams; Frances E Lund; Troy D Randall
Journal:  Immunity       Date:  2012-03-29       Impact factor: 31.745

6.  Follicular B cell trafficking within the spleen actively restricts humoral immune responses.

Authors:  Kristen L Hoek; Laura E Gordy; Patrick L Collins; Vrajesh V Parekh; Thomas M Aune; Sebastian Joyce; James W Thomas; Luc Van Kaer; Eric Sebzda
Journal:  Immunity       Date:  2010-08-05       Impact factor: 31.745

7.  EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.

Authors:  Wendy Béguelin; Relja Popovic; Matt Teater; Yanwen Jiang; Karen L Bunting; Monica Rosen; Hao Shen; Shao Ning Yang; Ling Wang; Teresa Ezponda; Eva Martinez-Garcia; Haikuo Zhang; Yupeng Zheng; Sharad K Verma; Michael T McCabe; Heidi M Ott; Glenn S Van Aller; Ryan G Kruger; Yan Liu; Charles F McHugh; David W Scott; Young Rock Chung; Neil Kelleher; Rita Shaknovich; Caretha L Creasy; Randy D Gascoyne; Kwok-Kin Wong; Leandro Cerchietti; Ross L Levine; Omar Abdel-Wahab; Jonathan D Licht; Olivier Elemento; Ari M Melnick
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

8.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Authors:  Laura Pasqualucci; David Dominguez-Sola; Annalisa Chiarenza; Giulia Fabbri; Adina Grunn; Vladimir Trifonov; Lawryn H Kasper; Stephanie Lerach; Hongyan Tang; Jing Ma; Davide Rossi; Amy Chadburn; Vundavalli V Murty; Charles G Mullighan; Gianluca Gaidano; Raul Rabadan; Paul K Brindle; Riccardo Dalla-Favera
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

Review 9.  Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response.

Authors:  Hong Zan; Paolo Casali
Journal:  Front Immunol       Date:  2015-12-14       Impact factor: 7.561

10.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

View more
  46 in total

1.  The Histone Demethylase LSD1 Regulates B Cell Proliferation and Plasmablast Differentiation.

Authors:  Robert R Haines; Benjamin G Barwick; Christopher D Scharer; Parimal Majumder; Troy D Randall; Jeremy M Boss
Journal:  J Immunol       Date:  2018-09-19       Impact factor: 5.422

2.  Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression.

Authors:  Sanjay Chandrasekaran; Maiko Sasaki; Christopher D Scharer; Haydn T Kissick; Dillon G Patterson; Kelly R Magliocca; John T Seykora; Bishu Sapkota; David A Gutman; Lee A Cooper; Gregory B Lesinski; Edmund K Waller; Susan N Thomas; Sergei V Kotenko; Jeremy M Boss; Carlos S Moreno; Robert A Swerlick; Brian P Pollack
Journal:  Mol Cancer Res       Date:  2019-09-23       Impact factor: 5.852

3.  LSD1 Cooperates with Noncanonical NF-κB Signaling to Regulate Marginal Zone B Cell Development.

Authors:  Robert R Haines; Christopher D Scharer; Jenna L Lobby; Jeremy M Boss
Journal:  J Immunol       Date:  2019-09-06       Impact factor: 5.422

Review 4.  Epigenetic dynamics in normal and malignant B cells: die a hero or live to become a villain.

Authors:  Jared M Andrews; Jacqueline E Payton
Journal:  Curr Opin Immunol       Date:  2018-10-17       Impact factor: 7.486

5.  IgM, IgG, and IgA Influenza-Specific Plasma Cells Express Divergent Transcriptomes.

Authors:  Madeline J Price; Sakeenah L Hicks; John E Bradley; Troy D Randall; Jeremy M Boss; Christopher D Scharer
Journal:  J Immunol       Date:  2019-09-09       Impact factor: 5.422

6.  The BLIMP1-EZH2 nexus in a non-Hodgkin lymphoma.

Authors:  Kimberley Jade Anderson; Árný Björg Ósvaldsdóttir; Birgit Atzinger; Gunnhildur Ásta Traustadóttir; Kirstine Nolling Jensen; Aðalheiður Elín Lárusdóttir; Jón Thór Bergthórsson; Ingibjörg Hardardóttir; Erna Magnúsdóttir
Journal:  Oncogene       Date:  2020-06-12       Impact factor: 9.867

7.  Transcriptomic and epigenomic dynamics associated with development of human iPSC-derived GABAergic interneurons.

Authors:  George Andrew S Inglis; Ying Zhou; Dillon G Patterson; Christopher D Scharer; Yanfei Han; Jeremy M Boss; Zhexing Wen; Andrew Escayg
Journal:  Hum Mol Genet       Date:  2020-08-29       Impact factor: 6.150

Review 8.  Regulation of metabolic supply and demand during B cell activation and subsequent differentiation.

Authors:  Takeshi Egawa; Deepta Bhattacharya
Journal:  Curr Opin Immunol       Date:  2018-10-16       Impact factor: 7.486

9.  The Murine MHC Class II Super Enhancer IA/IE-SE Contains a Functionally Redundant CTCF-Binding Component and a Novel Element Critical for Maximal Expression.

Authors:  Parimal Majumder; Joshua T Lee; Benjamin G Barwick; Dillon G Patterson; Alexander P R Bally; Christopher D Scharer; Jeremy M Boss
Journal:  J Immunol       Date:  2021-04-16       Impact factor: 5.422

10.  EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner.

Authors:  Suresh Bugide; Romi Gupta; Michael R Green; Narendra Wajapeyee
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.